BSX
BOSTON SCIENTIFIC CORP
NYSE · Healthcare · Medical - Devices · US
$45.82
+5.33%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$44.81
From 52W high−56.35%
Volume34.47M
Market cap$66.41B
P/E (TTM)19.3x
P/S (TTM)3.2x
Div yield—
Key dataNov 4, 2026
Open
$44.81
From 52W high
−56.35%
Volume
34.47M
Market cap
$66.41B
ValuationView details →
P/E (Fwd)
14.8x
EV/EBITDA
14.4x
P/E (TTM)
19.3x
RSI (14)
57.1
MomentumView details →
1D Return
+5.33%
YTD Return
−51.76%
SummaryUpdated Sep 1, 2026
Boston Scientific Corporation (NYSE:BSX) is a leading global medical device company founded in 1979 and headquartered in Marlborough, Massachusetts. The company went public in 1992 and has since grown to become one of the world's largest medical technology companies, developing, manufacturing, and marketing medical devices used in various interventional medical specialties worldwide. Boston Scientific operates through three primary segments and has established itself as a major player in the medical device industry through both organic growth and strategic acquisitions.
Similar companies
Latest newsMore news →
BOSTON SCIENTIFIC CORP reported that a cyber disruption reduced its third-quarter growth and earnings.7h agoBlackstone Life Sciences and BOSTON SCIENTIFIC CORP agreed to jointly fund development of BOSTON SCIENTIFIC CORP’s Vitalyst minimally invasive heart pump in a deal valued at $455 million.2d agoBOSTON SCIENTIFIC CORP introduced a new operating model to improve the accuracy of future performance forecasts.7d ago